title: Combined cyclosporin A-steroid-MTX treatment in endogenous non-infectious uveitis.
abstract: Thirty-two patients with endogenous uveitis resistant to treatment with high doses of cortisone and other immunosuppressive agents were treated with cyclosporin A (at an initial dose of 5 mg/kg/die, subsequently modified according to individual clinical response), fluocortolone and methotrexate. Total and lasting disease remission was obtained in all patients, together with the recovery of normal visual acuity in 20 cases and its significant improvement in the remaining 12. Furthermore, in all patients the total disappearance of all ocular inflammatory activity was observed and maintained for a period of 10.87 +/- 5.31 (6-18) months. No signs of renal or hepatic toxicity were observed in any of the patients. A form of hirsutism appeared in only two cases.
authors.affiliation: Istituto di Patologia Speciale Medica I, Università degli Studi di Cagliari, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Pascalis
authors.forename: G
authors.initials: G
authors.lastname: Pia
authors.forename: G
authors.initials: G
authors.lastname: Aresu
authors.forename: T
authors.initials: T
authors.lastname: Frongia
authors.forename: L
authors.initials: L
authors.lastname: Barca
mesh_terms: D000293:Adolescent; D000328:Adult; D001327:Autoimmune Diseases / Q000150:complications; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005448:Fluocortolone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D014605:Uveitis / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D014792:Visual Acuity / Q000187:drug effects
chemical_list: D005448:Fluocortolone; D016572:Cyclosporine; D008727:Methotrexate